Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 16.05
-0.15 (-0.93%)
Jul 15, 2026, 3:33 PM CET
Navamedic ASA Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Navamedic ASA stock has a consensus rating of "Buy" and an average price target of kr 23.50. The average 1-year stock price forecast is 46.42% higher than the current stock price, while the lowest is kr 21.00 (+30.84%) and the highest is kr 26.00 (+61.99%).
Price Target: kr 23.50 (+46.42%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Navamedic ASA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
587.85M
from 565.36M
Increased by 3.98%
Revenue Next Year
643.45M
from 587.85M
Increased by 9.46%
EPS This Year
-0.06
from -1.03
EPS Next Year
0.45
from -0.06
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NOK.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 595.0M | ||
| Avg | 587.9M | ||
| Low | 580.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.2% | ||
| Avg | 4.0% | ||
| Low | 2.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.06 | ||
| Avg | -0.06 | ||
| Low | -0.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |